Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.12
+0.08 (1.07%)
At close: Apr 28, 2026, 4:00 PM EDT
7.10
-0.02 (-0.21%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Precision BioSciences Employees
Precision BioSciences had 68 employees as of December 31, 2025. The number of employees decreased by 40 or -37.04% compared to the previous year.
Employees
68
Change (1Y)
-40
Growth (1Y)
-37.04%
Revenue / Employee
$503,882
Profits / Employee
-$672,412
Market Cap
183.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -40 | -37.04% |
| Dec 31, 2024 | 108 | -1 | -0.92% |
| Dec 31, 2023 | 109 | -89 | -44.95% |
| Dec 31, 2022 | 198 | 0 | - |
| Dec 31, 2021 | 198 | -33 | -14.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsDTIL News
- 10 hours ago - Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting - Business Wire
- 4 days ago - Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 days ago - Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026 - Business Wire
- 13 days ago - Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - Business Wire
- 14 days ago - Precision BioSciences Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 6 weeks ago - Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update - Business Wire
- 6 weeks ago - Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program - Business Wire